Thyroid cancer has been increasing in incidence, with the number of reported cases in the
US rising by 25% over the last 3 years. With growing technological advances in the field and …

Recent modifications in the management of well‐differentiated thyroid cancer have resulted
in significant alterations in clinical approach. Utilizing a series of preoperative and …

The extent of surgery for thyroid cancer continues to be an area of controversy in endocrine
surgery. The options for treatment include thyroid lobectomy and isthmusectomy or a total …

In the last decades, a surprising increased incidence of differentiated thyroid cancer (DTC),
along with a precocious diagnosis of “small” tumors and microcarcinomas have been …

Lobectomy is increasingly performed for low-risk differentiated thyroid cancer (DTC) and
papillary thyroid microcarcinoma (PTMC). However, there is a continuous controversy about …

The incidence of thyroid cancer is increasing rapidly. A large percentage of new cases
identified fall into a low-risk category. As the incidence has increased, clinical experience …

Objective For 1–4 cm differentiated thyroid cancer (DTC), current ATA guideline
recommended hemithyroidectomy (HT) as an acceptable alternative initial procedure to total …

The extent of thyroid surgery for patients with low-and intermediate-risk differentiated thyroid
carcinoma (DTC), with a primary tumour< 4 cm and no extrathyroidal extension (ETE) or …

The vast majority of differentiated thyroid cancers (DTC) are characterized by an innocuous
nature, excellent patient survival, and limited treatment requirement. However, a significant …

AIMS: There is considerable controversy concerning the most appropriate surgical treatment
of patients with differentiated thyroid carcinoma (DTC). Although some authors have …